|
TWSG1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.800030E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.249800E-01 |
| Normal-vs-Stage2 |
4.526000E-01 |
| Normal-vs-Stage3 |
2.245800E-01 |
| Normal-vs-Stage4 |
4.420500E-03 |
| Stage1-vs-Stage2 |
7.676600E-01 |
| Stage1-vs-Stage3 |
4.606200E-01 |
| Stage1-vs-Stage4 |
7.642100E-03 |
| Stage2-vs-Stage3 |
8.314200E-01 |
| Stage2-vs-Stage4 |
1.402440E-01 |
| Stage3-vs-Stage4 |
1.155580E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.372240E-01 |
| Normal-vs-AfricanAmerican |
4.398000E-01 |
| Normal-vs-Asian |
2.485800E-01 |
| Caucasian-vs-AfricanAmerican |
8.936000E-01 |
| Caucasian-vs-Asian |
9.394400E-01 |
| AfricanAmerican-vs-Asian |
8.554200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.996000E-01 |
| Normal-vs-Female |
1.831790E-01 |
| Male-vs-Female |
9.093000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.988200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.182960E-01 |
| Normal-vs-Age(61-80Yrs) |
1.853170E-01 |
| Normal-vs-Age(81-100Yrs) |
2.205200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.022400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.969800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.710200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.995600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.071600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.228000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.643000E-03 |
| Classical-VS-Follicular |
2.846800E-01 |
| Classical-VS-Other |
4.293200E-01 |
| Classical-VS-Normal |
3.142800E-01 |
| Tall-VS-Follicular |
3.564000E-03 |
| Tall-VS-Other |
7.976200E-01 |
| Tall-VS-Normal |
4.939200E-03 |
| Follicular-VS-Other |
3.297200E-01 |
| Follicular-VS-Normal |
8.762000E-01 |
| Other-VS-Normal |
1.773950E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.161400E-01 |
| Normal-vs-N1 |
1.659710E-02 |
| N0-vs-N1 |
6.067900E-02 |
|
|
